Elilily警告将Zepbound与B12混为一谈可能会造成不安全的杂质, Eli Lilly warns compounded Zepbound with B12 may create unsafe impurities, urging patients to avoid unregulated versions.

Elilly警告说,其减重药物Zepbound的复合版本如果与维生素B12混合,可能会由于化学反应而产生未知的杂质,从而引起安全问题。 Eli Lilly has warned that compounded versions of its weight-loss drug Zepbound, when mixed with vitamin B12, may produce an unknown impurity due to a chemical reaction, raising safety concerns. 内部检测发现,这种杂质程度很高,其健康影响尚不得而知,有可能影响药物安全、毒性和免疫反应。 Internal testing found significant levels of this impurity, whose health effects are unknown, potentially affecting drug safety, toxicity, and immune response. 该公司敦促病人避免这些未经管制的配方,这些配方在未经林业发展局监督的情况下通过远程保健平台和复合药店出售,并支持林业发展局限制此类产品的努力。 The company urges patients to avoid these unregulated formulations, which are sold through telehealth platforms and compounding pharmacies without FDA oversight, and supports FDA efforts to restrict such products.